These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10230186)

  • 1. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontricyclic antidepressants: current trends in children and adolescents.
    Emslie GJ; Walkup JT; Pliszka SR; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):517-28. PubMed ID: 10230183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current knowledge of medications for the treatment of childhood anxiety disorders.
    Allen AJ; Leonard H; Swedo SE
    J Am Acad Child Adolesc Psychiatry; 1995 Aug; 34(8):976-86. PubMed ID: 7665455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication in adolescents: a review.
    Rifkin A; Wortman R; Reardon G; Siris SG
    J Clin Psychiatry; 1986 Aug; 47(8):400-8. PubMed ID: 2874127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anxiolytics in children.
    Siméon JG
    Encephale; 1993; 19(2):71-4. PubMed ID: 7903927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone in young autistic children: replication study and learning measures.
    Kolmen BK; Feldman HM; Handen BL; Janosky JE
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1570-8. PubMed ID: 9394942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the use of antidepressant and anxiolytic medications.
    Simeon JG; Ferguson HB
    Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics in children and adolescents.
    Campbell M; Rapoport JL; Simpson GM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):537-45. PubMed ID: 10230185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of clonidine in children with autism spectrum disorders.
    Ming X; Gordon E; Kang N; Wagner GC
    Brain Dev; 2008 Aug; 30(7):454-60. PubMed ID: 18280681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part I.
    Campbell M; Cueva JE
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1124-32. PubMed ID: 7559305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.